Braf V600-mutated Solid Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-07-28
Clinical Trial Update: A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid Tumors [Phase 1]
Phase 1 study of RO5212054 (PLX3603) in patients with BRAF V600-mutated advanced solid tumors has completed.